Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

UCSD’s Anthony Wynshaw-Boris Named Executive Editor of Human Molecular Genetics

 

September 21, 2005  |  

Anthony Wynshaw-Boris, M.D., Ph.D., director of the University of California, San Diego (UCSD) School of Medicine’s Center for Human Genetics and Genomics, has been named executive editor of the journal Human Molecular Genetics, which concentrates on research covering a wide range of topics in all aspects of human molecular genetics.

Wynshaw-Boris succeeds Huntington Willard, Ph.D., vice chancellor and director of the Institute for Genome Sciences and Policy at Duke University, who has served as the journal’s executive editor for 14 years.

In addition to his new role as the journal’s executive editor, Wynshaw-Boris will continue his duties as a UCSD professor of pediatrics and medicine, and chief of the Division of Genetics within the UCSD Department of Pediatrics. He has been a UCSD faculty member and medical researcher since 1999. Prior to that, he was head of Mouse Models Unit within the Genetic Disease Research Branch of the National Human Genome Research Institute, one of the National Institutes of Health.

Wynshaw-Boris is a Del Mar, California resident.

##

News Media Contact:

Sue Pondrom, 619-543-6163, spondrom@ucsd.edu

UCSD Health Sciences Communications HealthBeat: /news/

 




Media Contact

Share This Article


Related News

4/2/2020
Donations of personal protective equipment, food and money have flooded into UC San Diego Health, part of a community effort to treat and protect patients, staff and the community from COVID-19.
3/26/2020
Researchers at University of California San Diego School of Medicine are launching a pair of studies to answer critical questions regarding the roles COVID-19 may play in breast milk and pregnancy.
3/24/2020
Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients w ...
3/20/2020
Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.



Follow Us